On July 1, Quantinuum declined 5.06% in regular trading, trading at $79.19 per share, with turnover of approximately $50.71 million.

On the news front, the stock has experienced extreme volatility since multiple top Wall Street investment banks collectively initiated coverage on June 29. Nine institutions issued first-time ratings, with target prices ranging widely from $78 to $155, reflecting significant disagreement on the quantum computing company's valuation. JPMorgan set a $97 target with an Overweight rating, while Morgan Stanley was the most conservative with an Equalweight rating and $78 target. UBS ($93), Jefferies ($90), Mizuho ($90), Cantor Fitzgerald ($90), BofA ($100), Needham ($100), and Rosenblatt ($155) all gave Buy or equivalent ratings.

Despite the broadly bullish coverage, the stock surged then reversed on the coverage day, accumulating over 10% losses over three sessions before rebounding more than 5% yesterday. Today's renewed decline suggests the market has yet to reach consensus on how to value a quantum computing platform company that remains unprofitable, with its market capitalization near $197 billion at recent lows. Quantinuum IPO'd at $60 per share less than a month ago on June 5.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)